Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

AVXL Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 12, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Anavex Life Sciences Corp (AVXL)

Based on 9 analysts giving stock ratings to Anavex Life Sciences Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
22
Buy
56
Hold
22
Sell
0
Strong Sell
0
Anavex Life Sciences Corp

Anavex Life Sciences Corp. Stock Analysis AVXL

United States Health Care Micro Cap Report:
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. The company is headquartered in New York City, New York and currently employs 34 full-time employees. The company went IPO on 2006-04-13. The firm analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. Its pipeline products include ANAVEX 2-73 (blarcamesine) and ANAVEX 3-7. Its other programs include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037. ANAVEX 2-73 is being developed as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease and Parkinson’s disease, and in an oral liquid once-daily formulation for rare diseases such as Rett syndrome and Fragile X.
Read More

Anavex Life Sciences Corp (AVXL) Chart

Key Statistics of Anavex Life Sciences Corp (AVXL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$2.49$2.67

Today's Open

$2.50

Volume

780.95K

P/E Ratio (TTM)

-

52 Week Range

$2.41$13.99

Market Cap

251.14M

Avg. Volume

1.52M

Dividend Yield

-

Financial Metrics & Statements of Anavex Life Sciences Corp (AVXL)

FAQ's for Anavex Life Sciences Corp (AVXL)

  • According to Musaffa’s Shariah screening methodology, Anavex Life Sciences Corp (AVXL) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Anavex Life Sciences Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Anavex Life Sciences Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Anavex Life Sciences Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Anavex Life Sciences Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Anavex Life Sciences Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.